iShares Trust - iShares iBonds Oct 2025 Term TIPS ETF (IBIB) Stock Price

25.495 ▼ -0.005 (-0.02%)
Open: 25.49 Vol: 7.13K Day's range: 25.49 - 25.5099 Sep 30, 16:00 EDT
IEX quote, 15 minutes delayed during trading hours. Login or Signup to see real-time data
Free Stock Screener
Loading chart ...
IBIB Technical Analysis
5 mins 30 mins Hourly Daily Weekly
BUY BUY BUY BUY BUY
  5 mins 30 mins Hourly Daily Weekly
MA5 25.44▲ 25.44▲ 25.44▲ 25.49▲ 25.47▲
MA10 25.42▲ 25.41▲ 25.41▲ 25.48▲ 25.42▲
MA20 25.39▲ 25.39▲ 25.38▲ 25.46▲ 25.44▲
MA50 25.33▲ 25.36▲ 25.37▲ 25.40▲ 25.44▲
MA100 25.41▲ 25.43▲ 25.43▲ 25.43▲ 25.38▲
MA200 25.46▲ 25.43▲ 25.44▲ 25.44▲ N/A    
  5 mins 30 mins Hourly Daily Weekly
MACD 0.008▲ 0.011▲ 0.012▲ 0.001▲ 0.012▲
RSI 88.321▲ 83.502▲ 81.560▲ 80.432▲ 57.550▲
STOCH 100.000▲ 100.000▲ 100.000▲ 85.400▲ 88.563▲
WILL %R 0.000▲ 0.000▲ 0.000▲ -21.316▲ -27.941    
CCI 141.762▲ 143.249▲ 143.249▲ 150.134▲ 129.865▲
Latest Filters Detected On IBIB
▲ BREAK $IBIB Price Breaks 60 Days High Set Alert
▲ BREAK $IBIB Price Breaks 30 Days High Set Alert
▲ BREAK $IBIB Price Breaks 20 Days High Set Alert
▲ BREAK $IBIB Price Breaks 10 Days High Set Alert
CDL $IBIB Marubozu Candlestick Pattern Detected Set Alert
iShares Trust - iShares iBonds Oct 2025 Term TIPS ETF News
Biogen (BIIB) Expands Neurology Pipeline With Alcyone Buyout, Stock Seen Undervalued
Friday, September 26, 2025 09:59 PM
Biogen Inc. (NASDAQ:BIIB) ranks among the most undervalued NASDAQ stocks to buy now. On September 18, Biogen Inc. (NASDAQ:BIIB) announced that it had finalized a deal to acquire Alcyone Therapeutics ...
Biogen Faces FDA Setback On High-Dose Nusinersen Filing For Spinal Muscular Atrophy
Thursday, September 25, 2025 08:27 AM
On Tuesday, the U.S. Food and Drug Administration (FDA) issued a Complete Response Letter (CRL) for Biogen Inc.’s (NASDAQ: BIIB) supplemental New Drug Application (sNDA) for the high-dose regimen of ...
Biogen Provides Regulatory Update on High Dose Regimen of Nusinersen
Tuesday, September 23, 2025 02:22 PM
Biogen Inc. (Nasdaq: BIIB) today announced that the U.S. Food and Drug Administration (FDA) issued a Complete Response Letter (CRL) for the ...
IBIB historical stock data
date open high low close volume
30/09/25 25.49 25.5099 25.49 25.495 7,131
29/09/25 25.49 25.50 25.49 25.50 9,600
26/09/25 25.4843 25.495 25.48 25.485 11,330
25/09/25 25.4701 25.485 25.4701 25.485 2,927
24/09/25 25.48 25.48 25.47 25.475 409
23/09/25 25.48 25.48 25.47 25.475 3,752
22/09/25 25.47 25.4765 25.4679 25.475 1,509
19/09/25 25.47 25.475 25.47 25.475 255
18/09/25 25.46 25.4737 25.46 25.46 2,367
17/09/25 25.465 25.47 25.46 25.465 2,468
Quote Details
52wk Low:25.23
52wk High:25.67
Vol:7.13K
Avg Vol(3m):73.2K
1Y Chng:+0.85%
1M Chng:+0.47%
Add to Watch List
More Information
Sector N/A
Index N/A
Market Cap. 0.00